Last $3.69 USD
Change Today +0.14 / 3.94%
Volume 184.0K
GALT On Other Exchanges
Symbol
Exchange
NASDAQ CM
NASDAQ CM
As of 8:10 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James C. Czirr

Executive Chairman, Galectin Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 4 different industries.

See Board Relationships
58$437,214
As of Fiscal Year 2013

Background*

Mr. James C. Czirr, also known as Jim, served as the Chief Executive Officer of Minerva Biotechnologies Corp. Mr. Czirr served as the President of Extol Energy Corporation, a syndicator of oil and gas wells from 1982 to 1988. He served as an Executive Vice President of Business Development at Pro Pharmaceuticals Inc. (AKA Galectin Therapeutics, Inc.) since May 15, 2001. He was an Independent Corporate and Public Relations Consultant for over ten years, working with various ...

Read Full Background

Corporate Headquarters*

4960 Peachtree Industrial Boulevard
Norcross, Georgia 30071

United States

Phone: 678-620-3186
Fax: 770-864-1327

Board Members Memberships*

Former Chief Executive Officer and Director
1997-Present
Director and Member of Audit Committee
2001-Present
Executive Chairman

Education*

Master's Degree
College For Financial Planning, Inc.
Bachelor's Degree 1976
University of Michigan
Master's Degree
University of Toledo School of Business Administration

Other Affiliations*

Annual Compensation*

Salary$240,000
Bonus$120,025
Total Annual Compensation$360,025

Stock Options*

All Other Compensation$77,189
Exercisable Options416,667
Unexercisable Options250,000
Total Number of Options666,667

Total Compensation*

Total Annual Cash Compensation$437,214
Total Short Term Compensation$360,025
Other Long Term Compensation$77,189
Total Calculated Compensation$437,214
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALT:US $3.69 USD +0.14

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALECTIN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.